This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Prelude Therapeutis Incorporated. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Raul Andrew Leal: Innovator in CDK Inhibitors
Introduction
Raul Andrew Leal is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on CDK inhibitors. His innovative approach has led to advancements in the treatment of various diseases.
Latest Patents
Raul Andrew Leal holds 1 patent related to CDK inhibitors and their use as pharmaceuticals. The patent focuses on the development of pharmaceutical compositions that include CDK inhibitors, along with methods for their preparation and application. This work is crucial for enhancing therapeutic options in medicine.
Career Highlights
Leal is currently associated with Prelude Therapeutics Incorporated, where he continues to push the boundaries of pharmaceutical research. His expertise in the field has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Throughout his career, Raul has collaborated with talented individuals such as Liang Lu and Rupa Shetty. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Raul Andrew Leal's contributions to the field of pharmaceuticals, particularly through his work on CDK inhibitors, highlight his role as an influential inventor. His ongoing research and collaborations promise to lead to further advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile